Steward Partners Investment Advisory’s Avidity Biosciences RNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $630K | Sell |
22,183
-24,567
| -53% | -$698K | ﹤0.01% | 1189 |
|
|
2025
Q1 | $1.38M | Sell |
46,750
-1,700
| -4% | -$50.2K | 0.01% | 791 |
|
|
2024
Q4 | $1.41M | Sell |
48,450
-45,168
| -48% | -$1.31M | 0.01% | 745 |
|
|
2024
Q3 | $4.3M | Sell |
93,618
-9,582
| -9% | -$440K | 0.04% | 403 |
|
|
2024
Q2 | $4.22M | Buy |
103,200
+2,700
| +3% | +$110K | 0.04% | 368 |
|
|
2024
Q1 | $2.56M | Buy |
100,500
+41,500
| +70% | +$1.06M | 0.03% | 503 |
|
|
2023
Q4 | $534K | Buy |
59,000
+39,500
| +203% | +$357K | 0.01% | 970 |
|
|
2023
Q3 | $124K | Buy |
19,500
+16,500
| +550% | +$105K | ﹤0.01% | 1477 |
|
|
2023
Q2 | $33.3K | Buy |
+3,000
| New | +$33.3K | ﹤0.01% | 2053 |
|
|
2021
Q2 | – | Sell |
-150
| Closed | -$3.27K | – | 7344 |
|
|
2021
Q1 | $3.27K | Buy |
+150
| New | +$3.27K | ﹤0.01% | 3113 |
|